A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction.

Source:http://linkedlifedata.com/resource/pubmed/id/10356669

Download in:

View as

General Info

PMID
10356669